Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024. In the quarter to June 2026, revenue grew 8.80%, EPS grew 42.8% and free cash flow fell 43.5%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years, revenue growth for three.

512.38 3.06 −0.59%
Market cap
$6.7B
P/E
25.7×
Fwd P/E
20.4×
Dividend yield
0.49%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
1,576.88 1,666.72 1,782.65 1,938.56 2,079.58 2,139.26 2,134.96 2,264.42 2,431.29 2,529.98
Revenue Growth
2.17% 5.70% 6.96% 8.75% 7.27% 2.87% (0.20%) 6.06% 7.37% 4.06%
Gross Profit
461.45 516.19 555.00 617.43 701.39 769.80 765.09 798.81 854.35 823.18
Operating Income
178.75 113.04 243.63 257.38 389.68 343.04 343.50 340.57 366.49 338.25
EBT
177.05 116.92 239.60 261.61 395.99 350.31 329.68 350.37 399.47 355.78
Income after Tax
108.74 98.18 205.54 219.92 319.47 268.55 249.62 272.51 302.00 265.24
Net Income Common
108.74 98.18 205.54 219.92 319.47 268.55 249.62 272.51 302.00 265.24
EPS (Diluted)
6.48 5.86 12.23 13.31 19.48 16.85 16.53 17.93 19.89 18.34
Shares (Diluted, Weighted)
16.79 16.74 16.80 16.53 16.40 15.94 15.10 15.20 15.19 14.46
Gross Margin
29.26% 30.97% 31.13% 31.85% 33.73% 35.98% 35.84% 35.28% 35.14% 32.54%
EBIT Margin
11.34% 6.78% 13.67% 13.28% 18.74% 16.04% 16.09% 15.04% 15.07% 13.37%
Net Profit Margin
6.90% 5.89% 11.53% 11.34% 15.36% 12.55% 11.69% 12.03% 12.42% 10.48%
Free Cash Flow Margin
6.06% 5.89% 13.14% 12.80% 20.78% 11.72% 11.94% 12.10% 15.27% 13.05%
EBITDA
215.76 150.41 283.38 302.89 446.57 402.39 403.01 402.01 429.86 403.41
EBIT
178.75 113.04 243.63 257.38 389.68 343.04 343.50 340.57 366.49 338.25

Show all line items

In millions of $ except per-share values · columns are period end dates